The global pharmaceutical industry is continuously evolving, with vaccine research and development becoming one of the most important areas driving innovation. From June 16th to 18th, 2026, CPHI & PMEC China 2026 (The 24th World Pharmaceutical Ingredients China Exhibition) will be held at the Shanghai New International Expo Centre, bringing together leading pharmaceutical companies, technology providers, and industry experts from around the world.

As a professional company specializing in the research, development, and innovation of vaccine adjuvants, Chengdu Jicang Biotechnology will participate in this important industry event. The company sincerely welcomes pharmaceutical professionals, research institutions, partners, and industry colleagues to visit its booth, explore advanced adjuvant technologies, and discuss future cooperation opportunities.

Exhibition Information: Meet Jicang Biotechnology in Shanghai

Exhibition: CPHI & PMEC China 2026
Date: June 16-18, 2026
Venue: Shanghai New International Expo Centre
Booth: Hall W9 - A27

Visitors are welcome to visit Chengdu Jicang Biotechnology at Booth W9-A27 to learn more about its innovative vaccine adjuvant products, technical capabilities, and customized development services.

Showcasing Next-Generation Vaccine Adjuvant Solutions

At CPHI & PMEC China 2026, Chengdu Jicang Biotechnology will present its comprehensive vaccine adjuvant solutions, covering core adjuvant molecules, premixed adjuvant systems, formulation development, process optimization, and regulatory support.

As a trusted vaccine adjuvant supplier, Jicang Biotechnology focuses on providing professional support from early-stage research to commercial-scale production.

1. Core Adjuvant Molecules Supporting Vaccine Development

Chengdu Jicang Biotechnology provides a wide range of key adjuvant molecules designed to support different stages of vaccine research and manufacturing.

The product portfolio includes:

• QS-21
• QS-7
• 3D-MPLA

To meet different application requirements, the company offers multiple quality grades, including:

• GLP research-grade materials for laboratory studies
• GMP-grade materials for clinical and commercial production

The product supply system covers different quantities from milligram-level research requirements to gram and kilogram-scale manufacturing needs.

In addition, customized purification and processing services are available according to customer requirements, including raw materials, intermediate products, and highly purified finished products.

2. Advanced Premixed Adjuvant Systems for Human and Veterinary Vaccines

Different antigens require different immune stimulation strategies. Chengdu Jicang Biotechnology combines formulation expertise with practical development experience to provide customized premixed adjuvant solutions.

The company has developed multiple adjuvant platforms, including:

• Nanoparticle-based adjuvants
• Liposome adjuvants
• Micron crystal adjuvants
• TLR agonist adjuvant systems

Through antigen compatibility evaluation and formulation optimization, Jicang Biotechnology helps customers develop suitable vaccine formulations with improved stability and targeted immune responses.

3. Comprehensive Formulation Development and Process Support

Successful vaccine commercialization requires not only effective adjuvant components but also reliable formulation technology and scalable production processes.

Chengdu Jicang Biotechnology provides professional technical services covering:

Pre-formulation Research

Evaluating key formulation factors, studying component interactions, and identifying optimal formulation strategies.

Formulation Design and Optimization

Developing stable vaccine adjuvant systems according to antigen characteristics and product requirements.

Process Scale-Up and Validation

Supporting the transition from laboratory research to larger-scale production while maintaining consistency and quality.

Analytical Method Development

Establishing scientific testing methods and quality evaluation systems to ensure reliable batch performance.

4. Regulatory Compliance and Quality Assurance Support

Quality and regulatory compliance are essential factors in vaccine development. Chengdu Jicang Biotechnology places strong emphasis on quality management and documentation support.

The company provides:

• ISO9001-compliant raw material documentation
• GLP/GMP-grade technical data packages
• Registration support materials
• Quality evaluation documentation

These services help customers meet regulatory requirements during vaccine development and commercialization.

Connect with Jicang Biotechnology at CPHI & PMEC China 2026

CPHI & PMEC China 2026 provides an excellent platform for pharmaceutical companies, research organizations, and technology partners to exchange ideas and explore cooperation opportunities.

During the exhibition, Chengdu Jicang Biotechnology will showcase its latest vaccine adjuvant technologies and professional development capabilities. Visitors can communicate directly with the company's technical and business teams to discuss product requirements, cooperation models, and customized solutions.

Exhibition Location: Shanghai New International Expo Centre
Booth Number: Hall W9 - A27
Date: June 16-18, 2026

Chengdu Jicang Biotechnology looks forward to meeting industry partners at CPHI & PMEC China 2026 and working together to advance innovative vaccine development worldwide.

https://en.jicangbio.com/chengdu-jicang-biotechnology-invites-you-to-cphi-pmec-china-2026.html